Properties of mutated murine α4β2 nicotinic receptors linked to partial epilepsy

Neuroscience Letters

Volumn 434, Issue 2, 2008, Pages 165-169

  Lipovsek, Marcela ^a   Plazas, Paola ^a   Savino, Jessica ^a   Klaassen, Alwin ^b   Boulter, Jim ^b   Elgoyhen, Ana Belén ^a,c   Katz, Eleonora ^a,c  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

ACh; Desensitization; Epilepsy; Ion channels; Nicotinic receptors

Indexed keywords

ACETYLCHOLINE; ALPHA4BETA2 NICOTINIC RECEPTOR; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; GENE INSERTION; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; XENOPUS;

ACETYLCHOLINE; ANIMALS; CHOLINERGIC AGENTS; EPILEPSIES, PARTIAL; GENES, DOMINANT; HETEROZYGOTE; HOMOZYGOTE; ION CHANNEL GATING; MICE; MODELS, CHEMICAL; MUTAGENESIS; OOCYTES; PATCH-CLAMP TECHNIQUES; RECEPTORS, NICOTINIC; XENOPUS;

EID: 40849106384     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.12.061     Document Type: Article

References (23)

1. Anand R., Conroy W.G., Schoepfer R., Whiting P., and Lindstrom J. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 266 (1991) 11192-11198
2. Bertrand S., Weiland S., Berkovic S.F., Steinlein O.K., and Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. Br. J. Pharmacol. 125 (1998) 751-760
3. Combi R., Dalpra L., Tenchini M.L., and Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy-a critical overview. J. Neurol. 251 (2004) 923-934
4. De Fusco M., Becchetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., Ballabio A., Wanke E., and Casari G. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat. Genet. 26 (2000) 275-276
5. Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F., and Boulter J. Alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3501-3506
6. Figl A., Viseshakul N., Shafaee N., Forsayeth J., and Cohen B.N. Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response. J. Physiol. 513 Pt 3 (1998) 655-670
7. Gotti C., Zoli M., and Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol. Sci. 27 (2006) 482-491
8. Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K., Kaneko S., and Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 53 (1999) 1749-1753
9. Itier V., and Bertrand D. Mutations of the neuronal nicotinic acetylcholine receptors and their association with ADNFLE. Neurophysiol. Clin. 32 (2002) 99-107
10. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 3 (2002) 102-114
11. Klaassen A., Glykys J., Maguire J., Labarca C., Mody I., and Boulter J. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 19152-19157
12. Kuryatov A., Gerzanich V., Nelson M., Olale F., and Lindstrom J. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J. Neurosci. 17 (1997) 9035-9047
13. Leniger T., Kananura C., Hufnagel A., Bertrand S., Bertrand D., and Steinlein O.K. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 44 (2003) 981-985
14. Miyazawa A., Fujiyoshi Y., and Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423 (2003) 949-955
15. Moroni M., and Bermudez I. Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types. J. Mol. Neurosci. 30 (2006) 95-96
16. Moulard B., Picard F., le Hellard S., Agulhon C., Weiland S., Favre I., Bertrand S., Malafosse A., and Bertrand D. Ion channel variation causes epilepsies. Brain Res. Brain Res. Rev. 36 (2001) 275-284
17. Plazas P.V., Katz E., Gomez-Casati M.E., Bouzat C., and Elgoyhen A.B. Stoichiometry of the {alpha}9{alpha}10 nicotinic cholinergic receptor. J. Neurosci. 25 (2005) 10905-10912
18. Quick M.W., and Lester R.A. Desensitization of neuronal nicotinic receptors. J. Neurobiol. 53 (2002) 457-478
19. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., and Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6 (1997) 943-947
20. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., and Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11 (1995) 201-203
21. Sutor B., and Zolles G. Neuronal nicotinic acetylcholine receptors and autosomal dominant nocturnal frontal lobe epilepsy: a critical review. Pflugers Arch. 442 (2001) 642-651
22. Teper Y., Whyte D., Cahir E., Lester H.A., Grady S.R., Marks M.J., Cohen B.N., Fonck C., McClure-Begley T., McIntosh J.M., Labarca C., Lawrence A., Chen F., Gantois I., Davies P.J., Petrou S., Murphy M., Waddington J., Horne M.K., Berkovic S.F., and Drago J. Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation. J. Neurosci. 27 (2007) 10128-10142
23. Weiland S., Bertrand D., and Leonard S. Neuronal nicotinic acetylcholine receptors: from the gene to the disease. Behav. Brain Res. 113 (2000) 43-56